Rankings
▼
Calendar
ORGO Q1 2021 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$355M
Q1 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$103M
+66.1% YoY
Gross Profit
$77M
75.1% margin
Operating Income
$13M
12.3% margin
Net Income
$10M
9.7% margin
EPS (Diluted)
$0.07
QoQ Revenue Growth
-4.0%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$6M
Stock-Based Comp.
$698,000
Balance Sheet
Total Assets
$319M
Total Liabilities
$162M
Stockholders' Equity
$157M
Cash & Equivalents
$77M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$103M
$62M
+66.1%
Gross Profit
$77M
$43M
+79.5%
Operating Income
$13M
-$15M
+183.6%
Net Income
$10M
-$16M
+161.0%
Revenue Segments
Advanced Wound care
$91M
88%
Surgical and Sports Medicine
$12M
12%
← FY 2021
All Quarters
Q2 2021 →